These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22784230)

  • 1. Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area.
    Simonnet A; Cador M; Caille S
    Addict Biol; 2013 Nov; 18(6):930-6. PubMed ID: 22784230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus.
    Yazdi F; Jahangirvand M; Pirasteh AH; Moradi M; Haghparast A
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):39-46. PubMed ID: 26494513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats.
    Malinen H; Hyytiä P
    Alcohol Clin Exp Res; 2008 Nov; 32(11):1976-83. PubMed ID: 18782338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory role of the intra-accumbal CB1 receptor in protein level of the c-fos and pCREB/CREB ratio in the nucleus accumbens and ventral tegmental area in extinction and morphine seeking in the rats.
    Khaleghzadeh-Ahangar H; Khodagholi F; Shaerzadeh F; Haghparast A
    Brain Res Bull; 2018 Sep; 142():320-327. PubMed ID: 30170186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of concurrent blockade of OX2 and CB1 receptors in the ventral tegmental area on nicotine-induced place preference in rats.
    Azizi F; Fartootzadeh R; Alaei H; Reisi P
    Neurosci Lett; 2018 Sep; 684():121-126. PubMed ID: 30017709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.
    D'Souza MS; Markou A
    Neuropharmacology; 2011 Dec; 61(8):1399-405. PubMed ID: 21896278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
    Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
    Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area.
    Taslimi Z; Haghparast A; Hassanpour-Ezatti M; Safari MS
    Behav Brain Res; 2011 Feb; 217(1):41-6. PubMed ID: 20937330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
    de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
    Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tribute to: Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area [William Corrigall, Kathleen Coen and Laurel Adamson, Brain Res. 653 (1994) 278-284].
    Leri F; Vaccarino FJ
    Brain Res; 2016 Aug; 1645():61-4. PubMed ID: 26867702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
    Ahmad T; Laviolette SR
    Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
    Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration.
    Rodriguez JS; Boctor SY; Flores LC; Phelix CF; Martinez JL
    Neurosci Lett; 2011 Feb; 489(3):187-91. PubMed ID: 21167256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-accumbal CB1 receptor blockade reduced extinction and reinstatement of morphine.
    Khaleghzadeh-Ahangar H; Haghparast A
    Physiol Behav; 2015 Oct; 149():212-9. PubMed ID: 26057574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second-order schedule of food reinforcement in rats to examine the role of CB1 receptors in the reinforcement-enhancing effects of nicotine.
    Wing VC; Shoaib M
    Addict Biol; 2010 Oct; 15(4):380-92. PubMed ID: 20331564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.
    De Luca MA; Bimpisidis Z; Melis M; Marti M; Caboni P; Valentini V; Margiani G; Pintori N; Polis I; Marsicano G; Parsons LH; Di Chiara G
    Neuropharmacology; 2015 Dec; 99():705-14. PubMed ID: 26327678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
    Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
    Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.